European Medicines Agency - Regulatory - Regulation of medicines

D - Description

  Description

Name

Newcastle-CCLG - Newcastle Children's Cancer and Leukaemia Pharmacology Studies Group
Year of foundation 2000 The group previously existed as the Pharmacology Working Group of the UKCCSG (United Kingdom Children's Cancer Study Group) and, from 2006, as the Pharmacology Working Group of the CCLG (Children’s Cancer and Leukaemia Group).
Preterm and/or term newborn Yes
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network 0-21 years
Multispeciality? Specify No
Speciality/disease specific? Specify Oncology only
Conditions covered? Specify All cancers and leukaemias
Procedure/Intervention specific? Specify Clinical pharmacology studies
Number of collaborating countries 6
List of collaborating countries UK, USA, France, Germany, India, Australia
Number of collaborating centres 18
List of collaborating centres UK centres: Aberdeen Children's Hospital Addenbrookes Hospital, Cambridge Alder Hey Children's Hospital, Liverpool Birmingham Children's Hospital Bristol Royal Hospital for Children Children's Hospital of Wales, Cardiff Great Ormond Street Hospital Hospital for Sick Children, Glasgow John Radcliffe Hospital, Oxford Manchester Children's Hospital Royal Marsden Hospital Royal Victoria Infirmary, Newcastle Sheffield Children's Hospital Southampton General Hospital St James's Hospital, Leeds Royal Hospital for Sick Children, Edinburgh Royal Hospital for Sick Children, Belfast Christie Hospital, Manchester
Type of activity/studies
Clinical Studies Yes
Experimental research Yes
Other activity Initiation and coordination of studies focusing on the safety and ethics of carrying out research studies in a children's cancer setting.